Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of trabectedin vs doxorubicin-based chemotherapy in first-line translocation-related sarcomas
2008-002326-11Phase 3Completed
- Sponsor
- PharmaMar
- Start
- Jul 2008
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of trabectedin in soft tissue sarcoma (STS) (2 arms), sponsored by PharmaMar. Primary endpoint: Progression-free survival. Started Jul 2008; status: completed.
02
Drugs
trabectedin
03
Conditions
soft tissue sarcoma (STS)
Beyond the preview
Go deeper on 2008-002326-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002326-11.